Fed. Circ. Told 10X's IP Loss At Odds With Minerva Ruling
10X Genomics is asking the Federal Circuit to review a panel's decision upholding a ruling that the startup infringed Bio-Rad's patents on microfluidic chips used for genetic sequencing, arguing that it...To view the full article, register now.
Already a subscriber? Click here to view full article